PL1754491T3 - Preparat do oczu do wchłaniania przezskórnego zawierający agonistę receptora muskarynowego - Google Patents

Preparat do oczu do wchłaniania przezskórnego zawierający agonistę receptora muskarynowego

Info

Publication number
PL1754491T3
PL1754491T3 PL05743236T PL05743236T PL1754491T3 PL 1754491 T3 PL1754491 T3 PL 1754491T3 PL 05743236 T PL05743236 T PL 05743236T PL 05743236 T PL05743236 T PL 05743236T PL 1754491 T3 PL1754491 T3 PL 1754491T3
Authority
PL
Poland
Prior art keywords
receptor agonist
muscarinic receptor
preparation containing
ophthalmic
absorption type
Prior art date
Application number
PL05743236T
Other languages
English (en)
Inventor
Akiharu Isowaki
Akira Ohtori
Original Assignee
Senju Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharma Co filed Critical Senju Pharma Co
Publication of PL1754491T3 publication Critical patent/PL1754491T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PL05743236T 2004-05-21 2005-05-20 Preparat do oczu do wchłaniania przezskórnego zawierający agonistę receptora muskarynowego PL1754491T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2004151248 2004-05-21
PCT/JP2005/009709 WO2005113002A1 (ja) 2004-05-21 2005-05-20 ムスカリン受容体作動薬を含有する眼科用経皮吸収型製剤
EP05743236A EP1754491B1 (en) 2004-05-21 2005-05-20 Ophthalmic percutaneously absorbed preparation containing muscarinic receptor agonist

Publications (1)

Publication Number Publication Date
PL1754491T3 true PL1754491T3 (pl) 2010-08-31

Family

ID=35428256

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05743236T PL1754491T3 (pl) 2004-05-21 2005-05-20 Preparat do oczu do wchłaniania przezskórnego zawierający agonistę receptora muskarynowego

Country Status (9)

Country Link
US (1) US20070053964A1 (pl)
EP (1) EP1754491B1 (pl)
JP (1) JP4308255B2 (pl)
CN (1) CN1819846A (pl)
AT (1) ATE459351T1 (pl)
DE (1) DE602005019724D1 (pl)
ES (1) ES2342085T3 (pl)
PL (1) PL1754491T3 (pl)
WO (1) WO2005113002A1 (pl)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1852106A4 (en) * 2005-02-17 2009-08-26 Senju Pharma Co SOLID OPHTHALMIC MEDICINE FOR EXTERNAL USE
US20090318422A1 (en) * 2006-08-28 2009-12-24 Akiharu Isowaki Ophthalmic percutaneous absorption type preparation
JP4746714B2 (ja) * 2008-05-16 2011-08-10 Ａｘｉｓ株式会社 線維筋痛症治療用医薬組成物
WO2010135731A1 (en) * 2009-05-22 2010-11-25 Kaufman Herbert E Preparations and methods for ameliorating or reducing presbyopia
US8299079B2 (en) 2009-05-22 2012-10-30 Kaufman Herbert E Preparations and methods for ameliorating or reducing presbyopia
LT2493474T (lt) * 2009-10-30 2019-10-10 Intratus, Inc. Būdai ir kompozicijos prolonguotam vaistų įvedimui
US8900626B2 (en) 2011-06-20 2014-12-02 Senju Usa, Inc. Transdermal drug delivery system and method of using the same
CN102846607A (zh) * 2012-04-09 2013-01-02 珠海亿邦制药股份有限公司 一种以盐酸西维美林为活性成分的固体制剂及其应用
WO2016159351A1 (ja) * 2015-04-03 2016-10-06 参天製薬株式会社 涙腺ドラッグデリバリーシステム
JP2016210780A (ja) * 2015-05-12 2016-12-15 参天製薬株式会社 アゾール系抗真菌薬の眼瞼皮膚への投与
HUE058931T2 (hu) 2018-04-24 2022-09-28 Allergan Inc Pilokarpin hidroklorid alkalmazása presbyopia kezelésére
US20210369686A1 (en) * 2018-10-06 2021-12-02 Biotheravision Llc Ophthalmic preparations of muscarinic agonist and methods of use
WO2020123470A1 (en) * 2018-12-10 2020-06-18 The Regents Of The University Of California Salivary gland regeneration
TWI809317B (zh) * 2020-09-29 2023-07-21 美商百歐賽那生技公司 蕈毒鹼性促效劑眼用製劑及其用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5366739A (en) * 1992-08-06 1994-11-22 Deo Corporation Method of ophthalmic drug delivery
DE4313928C2 (de) * 1993-04-28 1996-09-19 Lohmann Therapie Syst Lts Transdermales therapeutisches System zur kontrollierten Abgabe von Pilocarpin an die Haut, Verfahren zu seiner Herstellung und seine Verwendung
US5744155A (en) * 1993-08-13 1998-04-28 Friedman; Doron Bioadhesive emulsion preparations for enhanced drug delivery
WO2001026648A1 (en) * 1999-10-13 2001-04-19 Senju Pharmaceutical Co., Ltd. Ophthalmic adhesive preparations for percutaneous absorption
JP3677421B2 (ja) * 1999-12-27 2005-08-03 扶桑薬品工業株式会社 涙液分泌促進組成物
US6277855B1 (en) * 2000-04-21 2001-08-21 Inspire Pharmaceuticals, Inc. Method of treating dry eye disease with nicotinic acetylcholine receptor agonists
US20060036220A1 (en) * 2003-01-22 2006-02-16 Kohji Kawahara Percutaneous absorption preparation for treating ophthalmic disease, use thereof and method for migration of ophthalmic remedy into topical tissue in eye
CA2529036A1 (en) * 2003-07-03 2005-02-03 Eli Lilly And Company Indane derivates as muscarinic receptor agonists

Also Published As

Publication number Publication date
CN1819846A (zh) 2006-08-16
JPWO2005113002A1 (ja) 2008-03-27
EP1754491B1 (en) 2010-03-03
ATE459351T1 (de) 2010-03-15
JP4308255B2 (ja) 2009-08-05
ES2342085T3 (es) 2010-07-01
EP1754491A4 (en) 2008-09-03
EP1754491A1 (en) 2007-02-21
WO2005113002A1 (ja) 2005-12-01
DE602005019724D1 (de) 2010-04-15
US20070053964A1 (en) 2007-03-08

Similar Documents

Publication Publication Date Title
PL1754491T3 (pl) Preparat do oczu do wchłaniania przezskórnego zawierający agonistę receptora muskarynowego
PE20081441A1 (es) Subtipo de amidas selectivas de diazabicicloalcanos
MX2011010347A (es) Derivados sustituidos de azoantraceno, composiciones farmaceuticas y metodos de uso de los mismos.
WO2009077736A3 (en) A medicament comprising a parasympathetic agonist and a sympathetic antagonist or a sympathetic agonist
IN2013MN01699A (pl)
AU2003257588A1 (en) REMEDY FOR GLAUCOMA COMPRISING Rho KINASE INHIBITOR AND PROSTAGLANDINS
PE20060312A1 (es) Derivados de tetrahidronaftiridina como ligandos del receptor h3 de histamina
WO2009062118A3 (en) Modulation of protein trafficking
PE20010133A1 (es) NUEVAS COMPOSICIONES DE MEDICAMENTOS A BASE DE COMPUESTOS ANTICOLINERGICAMENTE ACTIVOS Y ß-MIMETICOS
WO2008134518A3 (en) Methods and compounds for vitamin d therapy
NO20060612L (no) Spiro [1-azabicyklo[2.2.2]-oktan-3,5'-oksazolidin]-2'-on-derivater med affinitet til alfa-7-nikotin-acetylcholin reseptoren
ATE406882T1 (de) Zusammensetzungen zur normalisierung des zirkadianen rythmus
ATE444061T1 (de) Transdermales therapeutisches system für parkinson-krankheit mit hohen rotigotin- plasmaspiegeln
RU2010148787A (ru) Чрескожно абсорбируемый препарат
ES2337596T3 (es) Antagonistas del receptor de glucacion, preparacion y usos terapeuticaos.
WO2006017188A3 (en) Memantine as adjunctive treatment to atypical antipsychotics in schizophrenia patients
WO2008045330A3 (en) Effective delivery of cross-species a3 adenosine-receptor antagonists to reduce intraocular pressure
WO2007075695A3 (en) Use of benzo-fused heterocycle sulfamide derivatives for the treatment of mania and bipolar disorder
MX2007004976A (es) Antagonistas de receptor m1 y/o m3 en combinacion con otros compuestos activos para tratar trastornos respiratorios.
DE60043017D1 (de) Zusammensetzung für perkutane Absorption mit einem melantoninrezeptor-agonistisch wirkendem Wirkstoff
WO2005115432A3 (en) Treatment of ocular diseases and disorders using lantibiotic compositions
ATE361065T1 (de) Pharmazeutische zusammensetzung zur kontrolle des blutzuckers bei patienten mit typ 2 diabetes
DE602006001699D1 (de) Stabile pharmazeutische Zusammensetzung mit Linezolid Form IV
EP3342423A1 (en) Transdermally absorptive composition
ES2193751T3 (es) Delta3-piperidinas triciclicas como antagonistas alfa2.